Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

Similar articles for PubMed (Select 23204233)

1.

Novel oncogene-induced metastatic prostate cancer cell lines define human prostate cancer progression signatures.

Ju X, Ertel A, Casimiro MC, Yu Z, Meng H, McCue PA, Walters R, Fortina P, Lisanti MP, Pestell RG.

Cancer Res. 2013 Jan 15;73(2):978-89. doi: 10.1158/0008-5472.CAN-12-2133. Epub 2012 Nov 30.

2.

Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.

Bland KI, Konstadoulakis MM, Vezeridis MP, Wanebo HJ.

Ann Surg. 1995 Jun;221(6):706-18; discussion 718-20.

3.

A model to study c-myc and v-H-ras induced prostate cancer progression in the Copenhagen rat.

Lehr JE, Pienta KJ, Yamazaki K, Pilat MJ.

Cell Mol Biol (Noisy-le-grand). 1998 Sep;44(6):949-59.

PMID:
9763199
4.

Suppression of primary tumor growth and the progression to metastasis with p53 adenovirus in human prostate cancer.

Eastham JA, Grafton W, Martin CM, Williams BJ.

J Urol. 2000 Sep;164(3 Pt 1):814-9.

PMID:
10953161
5.

Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model.

Gabril MY, Onita T, Ji PG, Sakai H, Chan FL, Koropatnick J, Chin JL, Moussa M, Xuan JW.

Gene Ther. 2002 Dec;9(23):1589-99.

6.

Protein-network modeling of prostate cancer gene signatures reveals essential pathways in disease recurrence.

Chen JL, Li J, Stadler WM, Lussier YA.

J Am Med Inform Assoc. 2011 Jul-Aug;18(4):392-402. doi: 10.1136/amiajnl-2011-000178.

7.

Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancer.

Thompson TC, Park SH, Timme TL, Ren C, Eastham JA, Donehower LA, Bradley A, Kadmon D, Yang G.

Oncogene. 1995 Mar 2;10(5):869-79.

PMID:
7534899
8.
9.

Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer.

Berezovska OP, Glinskii AB, Yang Z, Li XM, Hoffman RM, Glinsky GV.

Cell Cycle. 2006 Aug;5(16):1886-901. Epub 2006 Aug 15.

10.

Oncogene-mediated transformation of fetal rat colon in vitro.

Pories S, Jaros K, Steele G Jr, Pauley A, Summerhayes IC.

Oncogene. 1992 May;7(5):885-93.

PMID:
1373876
11.

Gene expression profiling predicts clinical outcome of prostate cancer.

Glinsky GV, Glinskii AB, Stephenson AJ, Hoffman RM, Gerald WL.

J Clin Invest. 2004 Mar;113(6):913-23.

12.

SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression.

Ding Z, Wu CJ, Chu GC, Xiao Y, Ho D, Zhang J, Perry SR, Labrot ES, Wu X, Lis R, Hoshida Y, Hiller D, Hu B, Jiang S, Zheng H, Stegh AH, Scott KL, Signoretti S, Bardeesy N, Wang YA, Hill DE, Golub TR, Stampfer MJ, Wong WH, Loda M, Mucci L, Chin L, DePinho RA.

Nature. 2011 Feb 10;470(7333):269-73. doi: 10.1038/nature09677. Epub 2011 Feb 2.

13.

Context-dependent hormone-refractory progression revealed through characterization of a novel murine prostate cancer cell line.

Watson PA, Ellwood-Yen K, King JC, Wongvipat J, Lebeau MM, Sawyers CL.

Cancer Res. 2005 Dec 15;65(24):11565-71.

14.

Experimental oncogene induced prostate cancer.

Thompson TC, Kadmon D, Timme TL, Merz VW, Egawa S, Krebs T, Scardino PT, Park SH.

Cancer Surv. 1991;11:55-71.

PMID:
1726789
15.

MKK4 suppresses metastatic colonization by multiple highly metastatic prostate cancer cell lines through a transient impairment in cell cycle progression.

Szmulewitz RZ, Clark R, Lotan T, Otto K, Taylor Veneris J, Macleod K, Rinker-Schaeffer C.

Int J Cancer. 2012 Feb 1;130(3):509-20. doi: 10.1002/ijc.26005. Epub 2011 Apr 25.

16.

Identification of a cyclin D1 network in prostate cancer that antagonizes epithelial-mesenchymal restraint.

Ju X, Casimiro MC, Gormley M, Meng H, Jiao X, Katiyar S, Crosariol M, Chen K, Wang M, Quong AA, Lisanti MP, Ertel A, Pestell RG.

Cancer Res. 2014 Jan 15;74(2):508-19. doi: 10.1158/0008-5472.CAN-13-1313. Epub 2013 Nov 26.

17.

Prostate cancer progression, metastasis, and gene expression in transgenic mice.

Perez-Stable C, Altman NH, Mehta PP, Deftos LJ, Roos BA.

Cancer Res. 1997 Mar 1;57(5):900-6.

19.

Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity.

Kim J, Roh M, Abdulkadir SA.

BMC Cancer. 2010 Jun 1;10:248. doi: 10.1186/1471-2407-10-248.

20.

Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression.

Wu GJ, Wu MW, Wang SW, Liu Z, Qu P, Peng Q, Yang H, Varma VA, Sun QC, Petros JA, Lim SD, Amin MB.

Gene. 2001 Nov 14;279(1):17-31.

PMID:
11722842
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk